Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2018
19th World Conference on Lung Cancer
Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2384
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
MS02 - The Future of IO
- Type: Mini Symposium
- Track: Immunooncology
- Presentations: 6
- Coordinates: 9/24/2018, 10:30 - 12:00, Room 106
-
+
MS02.01 - What Is/Will Be the Optimal Duration of Therapy with IO?
10:30 - 10:45 | Presenter: David R. Spigel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA04 - Novel Approaches with IO
- Type: Mini Oral Abstract Session
- Track: Immunooncology
- Presentations: 12
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 107
-
+
MA04.02 - Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1
13:35 - 13:40 | Presenter: Edward B Garon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA05 - Clinical Trials in IO
- Type: Oral Abstract Session
- Track: Advanced NSCLC
- Presentations: 8
- Coordinates: 9/24/2018, 13:30 - 15:00, Room 106
-
+
OA05.05 - Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
14:15 - 14:25 | Presenter: Fabrice Barlesi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 112
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.01-79 - CheckMate 817: Safety of Flat-Dose Nivolumab Plus Weight-Based Ipilimumab for the First-line (1L) Treatment of Advanced NSCLC
16:45 - 18:00 | Presenter: Luis Paz-Ares
- Abstract
Loading...
-
+
P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 64
- Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
-
+
P1.16-05 - Effect of Induction Chemotherapy in the PACIFIC Study
16:45 - 18:00 | Presenter: David R. Spigel
- Abstract
Loading...
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- Type: Plenary Session
- Track: Advanced NSCLC
- Presentations: 11
- Coordinates: 9/25/2018, 08:15 - 09:45, Plenary Hall
-
+
PL02.01 - Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC
08:15 - 08:25 | Presenter: Scott J Antonia
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 18
- Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
-
+
P2.12-04 - Liposomal Irinotecan vs Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed On/After Platinum-Based Therapy
16:45 - 18:00 | Author(s): Luis Paz-Ares
- Abstract
Loading...
-
+
P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- Type: Poster Viewing in the Exhibit Hall
- Track:
- Presentations: 47
- Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
-
+
P3.16-02 - Phase III Study of Canakinumab (ACZ885) as Adjuvant Therapy in Patients with Surgically Resected NSCLC
12:00 - 13:30 | Presenter: Edward B Garon
- Abstract
Loading...